Predictive Role of F₂-Isoprostanes as Biomarkers for Brain Damage after Neonatal Surgery

Table 1

Clinical data.

Gestational age (weeks)	38.9 (30.9–41.6)
Male, n (%)	36 (59%)
Birth weight (grams)	3000 (1405–4430)
Birth weight z-score	−0.25 (−2.1–1.9)
Small for gestational age, n (%)	2 (3%)
Preterm, n (%)	15 (25%)
Apgar score 1 minute	9 (2–10)
Apgar score 5 minutes	10 (2–10)
Postnatal age in days at time of surgery	2 (0–8)
Postnatal age in hours at time of surgery	39.9 (2–184)
Surgery
Thoracoscopy, n (%)	18 (30%)
Laparoscopy, n (%)	16 (26%)
Laparotomy, n (%)	23 (38%)
Duration surgery (minutes)	115 (23–475)
Duration anaesthesia (minutes)	189 (63–563)
Medication during anaesthesia
Sevoflurane, n (%)	60 (98%)
Isoflurane, n (%)	1 (2%)
Sufentanil, n (%)	60 (98%)
Propofol, n (%)	14 (23%)
Morphine, n (%)	17 (28%)
Caudal analgesia, n (%)	13 (21%)
Suxamethonium, n (%)	1 (2%)
Atracurium, n (%)	51 (84%)
Rocuronium, n (%)	9 (15%)

Data displayed in median (range) or indicated otherwise.